This company has been marked as potentially delisted and may not be actively trading. Amryt Pharma (AMYT) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Amryt Pharma Short Interest DataAmryt Pharma (AMYT) has a short interest of 229,500 shares. This marks a 89.36% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 757,360 shares to cover all short positions.Current Short Interest229,500 sharesPrevious Short Interest121,200 sharesChange Vs. Previous Month+89.36%Dollar Volume Sold Short$3.35 millionShort Interest Ratio0.3 Days to CoverLast Record DateMarch 31, 2023Outstanding Shares63,960,000 sharesPercentage of Shares Shorted0.36%Today's Trading Volume2,389,400 sharesAverage Trading Volume757,360 sharesToday's Volume Vs. Average315% Short Selling Amryt Pharma? Sign up to receive the latest short interest report for Amryt Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAMYT Short Interest Over TimeAMYT Days to Cover Over TimeAMYT Percentage of Float Shorted Over Time Amryt Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2023229,500 shares $3.35 million +89.4%N/A0.3 $14.58 3/15/2023121,200 shares $1.76 million +56.2%N/A0.2 $14.56 2/28/202377,600 shares $1.13 million +47.5%N/A0.1 $14.61 2/15/202352,600 shares $769.54 thousand -6.9%N/A0.1 $14.63 1/31/202356,500 shares $826.60 thousand -33.0%N/A0.1 $14.63 1/15/202384,300 shares $1.24 million +41.4%N/A0.2 $14.72 12/30/202259,600 shares $435.08 thousand -20.5%N/A0.2 $7.30 12/15/202275,000 shares $523.13 thousand +9.2%N/A2 $6.98 11/30/202268,700 shares $489.14 thousand -22.0%N/A1.9 $7.12 11/15/202288,100 shares $631.68 thousand -15.2%N/A2.9 $7.17 Get the Latest News and Ratings for AMYT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amryt Pharma and its competitors with MarketBeat's FREE daily newsletter. 10/31/2022103,900 shares $709.64 thousand +19.6%N/A3.4 $6.83 10/15/202286,900 shares $590.92 thousand -2.9%N/A2.5 $6.80 9/30/202289,500 shares $619.34 thousand +17.0%N/A2.1 $6.92 9/15/202276,500 shares $564.57 thousand -16.9%N/A1.3 $7.38 8/31/202292,100 shares $667.73 thousand -1.4%N/A1.5 $7.25 8/15/202293,400 shares $702.37 thousand -5.7%N/A1.3 $7.52 7/31/202299,000 shares $718.74 thousand -3.6%N/A1.3 $7.26 7/15/2022102,700 shares $768.20 thousand +24.6%N/A1.2 $7.48 6/30/202282,400 shares $575.98 thousand -16.4%N/A1 $6.99 6/15/202298,600 shares $699.07 thousand -2.0%N/A1.2 $7.09 5/31/2022100,600 shares $804.80 thousand -27.2%N/A1.2 $8.00 5/15/2022138,100 shares $1.13 million +78.9%N/A1 $8.21 4/30/202277,200 shares $648.48 thousand +8.6%N/A0.5 $8.40 4/15/202271,100 shares $560.27 thousand -17.6%N/A0.5 $7.88 3/31/202286,300 shares $713.70 thousand -7.0%N/A0.6 $8.27 3/15/202292,800 shares $724.77 thousand +28.7%N/A0.6 $7.81 2/28/202272,100 shares $503.26 thousand +7.1%N/A0.5 $6.98 2/15/202267,300 shares $634.64 thousand -19.0%N/A0.5 $9.43 1/31/202283,100 shares $840.14 thousand -15.5%N/A0.7 $10.11 1/15/202298,300 shares $1.04 million +84.8%N/A0.7 $10.55 12/31/202153,200 shares $574.56 thousand -25.7%N/A0.4 $10.80 12/15/202171,600 shares $698.82 thousand +34.3%N/A0.6 $9.76 11/30/202153,300 shares $529.80 thousand -67.0%N/A0.4 $9.94 11/15/2021161,500 shares $1.81 million -30.2%N/A1.3 $11.18 10/29/2021231,300 shares $2.45 million -3.2%N/A1.9 $10.60 10/15/2021238,900 shares $2.81 million -25.0%N/A2 $11.78 9/30/2021318,700 shares $3.84 million -5.0%N/A3 $12.05 9/15/2021335,400 shares $3.80 million -5.9%N/A3.3 $11.33 8/31/2021356,400 shares $3.96 million -25.0%N/A3.7 $11.10 8/13/2021475,100 shares $5.11 million -41.1%N/A4.8 $10.75Is Elon's empire crumbling? (Ad)The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd. Click here to see the Tesla shock that could blindside everyone. 7/30/2021806,400 shares $8.31 million +6.7%N/A8.8 $10.31 7/15/2021755,800 shares $8.82 million -7.2%N/A9.5 $11.67 6/30/2021814,600 shares $9.88 million +4.4%N/A10.7 $12.13 6/15/2021780,000 shares $9.06 million +35.8%N/A11.1 $11.62 5/28/2021574,300 shares $6.75 million +22.7%N/A8.1 $11.75 5/14/2021468,000 shares $5.13 million +2,066.7%N/A7.9 $10.96 4/30/202121,600 shares $285.34 thousand +188.0%N/A0.4 $13.21 4/15/20217,500 shares $104.18 thousand -49.0%N/A0.3 $13.89 3/31/202114,700 shares $203.45 thousand -46.9%N/A0.7 $13.84 3/15/202127,700 shares $390.02 thousand +77.6%N/A1.4 $14.08 2/26/202115,600 shares $224.84 thousand -1.3%N/A0.9 $14.41 2/12/202115,800 shares $225.94 thousand +26.4%N/A0.9 $14.30 1/29/202112,500 shares $168.75 thousand +12.6%N/A0.5 $13.50 1/15/202111,100 shares $150.41 thousand No ChangeN/A0.4 $13.55 AMYT Short Interest - Frequently Asked Questions What is Amryt Pharma's current short interest? Short interest is the volume of Amryt Pharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 229,500 shares of AMYT short. Learn More on Amryt Pharma's current short interest. Is Amryt Pharma's short interest increasing or decreasing? Amryt Pharma saw a increase in short interest in March. As of March 31st, there was short interest totaling 229,500 shares, an increase of 89.4% from the previous total of 121,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Amryt Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Amryt Pharma: Zymeworks Inc. (10.16%), Chimerix, Inc. (4.27%), Avid Bioservices, Inc. (18.17%), Revance Therapeutics, Inc. (4.32%), Checkpoint Therapeutics, Inc. (6.19%), Aerovate Therapeutics, Inc. (21.72%), 2seventy bio, Inc. (5.37%), Acelyrin, Inc. (4.87%), Procaps Group S.A. (0.12%), OptiNose, Inc. (1.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.66 billion), TC Energy Corporation ($4.13 billion), Occidental Petroleum Corporation ($3.04 billion), Moderna, Inc. ($2.63 billion), Coinbase Global, Inc. ($2.51 billion), T. Rowe Price Group, Inc. ($2.29 billion), Paramount Global ($2.26 billion), Verisk Analytics, Inc. ($2.19 billion), Etsy, Inc. ($1.84 billion), and Voya Financial, Inc. ($1.67 billion). View all of the most shorted stocks. What does it mean to sell short Amryt Pharma stock? Short selling AMYT is an investing strategy that aims to generate trading profit from Amryt Pharma as its price is falling. AMYT shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Amryt Pharma? A short squeeze for Amryt Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AMYT, which in turn drives the price of the stock up even further. How often is Amryt Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMYT, twice per month. The most recent reporting period available is March, 31 2023. More Short Interest Resources from MarketBeat Related Companies Zymeworks Short Interest Chimerix Short Interest Avid Bioservices Short Interest Revance Therapeutics Short Interest Checkpoint Therapeutics Short Interest Aerovate Therapeutics Short Interest 2seventy bio Short Interest Acelyrin Short Interest Procaps Group Short Interest OptiNose Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AMYT) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amryt Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Amryt Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.